VOLITIONRX LTD (VNRX) Form S-3 — Jul 10, 2026
VolitionRx Limited filed a Form S-3 registration statement to facilitate the resale of up to 3,306,607 shares of common stock by selling stockholder Lind Global Asset Management XII LLC. The shares are issuable upon the conversion or repayment of outstanding secured convertible promissory notes issued in May 2025 ($7.5 million principal) and January 2026 ($2.4 million principal), as well as associated warrants. The Company will not receive any proceeds from these sales, which may be conducted at market or negotiated prices at the discretion of the selling stockholder.
Key figures
- Debt Amount
- $9,900,000
- Shares Offered
- 3,306,607
- Waiver legal fees
- $7,500
- Reverse split ratio
- 1:20
- Market cap default threshold
- $22,500,000
Price after filing
Close on the filing date to close N calendar days later (from $1.35). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.